Chao‐Po Lin
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Toxicology top 1%
Papers in
-
- Cancer therapeutics and mechanisms 9
- CRISPR and Genetic Engineering 9
- DNA Repair Mechanisms 7
- Pluripotent Stem Cells Research 7
- Advanced biosensing and bioanalysis techniques 6
- RNA Interference and Gene Delivery 5
- RNA regulation and disease 4
- Co-authors
- Leroy F. Liu (12 shared papers)Yi Lisa Lyu (10 shared papers)Anna M. Azarova (6 shared papers)Yuan‐Chin Tsai (4 shared papers)Yi Ban (3 shared papers)Lin He (5 shared papers)John E. Kerrigan (2 shared papers)James C. Wang (2 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Cancer Research (3 papers)Nucleic Acids Research (2 papers)Molecular Therapy (2 papers)Cell Reports (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Chao‐Po Lin
46 papers receiving 2.7k citations
Chao‐Po Lin's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 533
- Toxicology 123
- Molecular Biology 1.9k
- Oncology 637
- Cardiology and Cardiovascular Medicine 431
Countries citing papers authored by Chao‐Po Lin
This map shows the geographic impact of Chao‐Po Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Po Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Po Lin more than expected).
Fields of papers citing papers by Chao‐Po Lin
This network shows the impact of papers produced by Chao‐Po Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Po Lin. The network helps show where Chao‐Po Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chao‐Po Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane Hit paper breakdown → | 2007 | 501 |
| 2 | 2011 | 324 | |
| 3 | 2014 | 257 | |
| 4 | 2007 | 244 | |
| 5 | 2006 | 149 | |
| 6 | 2006 | 124 | |
| 7 | 2017 | 123 | |
| 8 | 2008 | 98 | |
| 9 | 2006 | 68 | |
| 10 | 2009 | 63 | |
| 11 | 2022 | 58 | |
| 12 | 2010 | 43 | |
| 13 | 2009 | 42 | |
| 14 | 2006 | 41 | |
| 15 | 2005 | 40 | |
| 16 | 2022 | 38 | |
| 17 | 2016 | 36 | |
| 18 | 2012 | 36 | |
| 19 | 2005 | 35 | |
| 20 | 2011 | 32 |
About Chao‐Po Lin
Chao‐Po Lin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 47 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), CRISPR and Genetic Engineering (9 papers), DNA Repair Mechanisms (7 papers), Pluripotent Stem Cells Research (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), RNA Interference and Gene Delivery (5 papers), MicroRNA in disease regulation (5 papers) and RNA regulation and disease (4 papers). The work is most often cited by research in Cancer Research (533 citations), Toxicology (123 citations), Molecular Biology (1.9k citations), Oncology (637 citations) and Cardiology and Cardiovascular Medicine (431 citations). Chao‐Po Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Leroy F. Liu, Yi Lisa Lyu, Anna M. Azarova, Yuan‐Chin Tsai, Yi Ban, Lin He, John E. Kerrigan, James C. Wang, Pengcheng Bu and Xingyue He. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Nucleic Acids Research, Molecular Therapy and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.